Target Validation Information
TTD ID	T91696
Target Name	Fibronectin (FN1)
Type of Target	Clinical trial
Action against Disease Model	Isoproterenol	Drug Info	Target of re-combinant protein drug. Xenograft studies in mice with prostate, colorectal and skin cancers have shown that AS1409 blocks cancer growth more effectively than an equivalent dose of untargeted IL12
References

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.